Skip To Main Content
Theodore Barlows on Muck Rack

Theodore Barlows

As seen in: The Journal of Allergy & Clinical Immunology
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Theodore

Contact Theodore, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

ZEPHYR 3: Reductions in Exacerbations and Healthcare Resource Utilization in Patients with Severe Asthma Treated with Benralizumab

|
By Donna Carstens, Yen Chung, Suranne Pan, Theodore Barlows
| The Journal of Allergy & Clinical Immunology Verified
Benralizumab is approved to treat patients with severe asthma (SA). The ZEPHYR 3 study assessed the clinical outcomes and healthcare resource utilization (HCRU) in patients with SA that were treated with benralizumab. To read this article in full you will need to make a payment Article info Copyright © 2022 Published by Elsevier Inc.
Open in Who Shared Issue with article?
See all 1 articles